• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

I期临床的原发性皮肤薄恶性黑色素瘤的部分回归。486例研究。

Partial regression in thin primary cutaneous malignant melanomas clinical stage I. A study of 486 cases.

作者信息

Søndergaard K, Hou-Jensen K

出版信息

Virchows Arch A Pathol Anat Histopathol. 1985;408(2-3):241-7. doi: 10.1007/BF00707986.

DOI:10.1007/BF00707986
PMID:3936263
Abstract

486 patients with primary cutaneous malignant melanoma clinical stage I were examined in order to evaluate the prognostic importance of partial regression in thin lesions. All the melanomas measured 1 mm or less in maximal thickness. The study showed that past regression with fibrotic scar tissue adversely affected survival in patients with thin melanomas. The 10 year survival was 95% for patients without regression in contrast to 79% for patients with past regression. It was, furthermore, demonstrated that active regression without fibrotic scar tissue did not influence survival significantly. The wider and the thicker the fibrotic area, the poorer the survival. Although the prognostic importance of this finding was not statistically significant, we suggest that the horizontal width of the fibrotic area in particular may be a valuable prognostic guide in thin melanomas with past regression.

摘要

对486例原发性皮肤恶性黑色素瘤临床I期患者进行了检查,以评估薄病灶中部分消退的预后重要性。所有黑色素瘤的最大厚度均为1毫米或更小。研究表明,伴有纤维化瘢痕组织的既往消退对薄黑色素瘤患者的生存有不利影响。无消退患者的10年生存率为95%,而有既往消退患者的10年生存率为79%。此外,还证明无纤维化瘢痕组织的活动性消退对生存无显著影响。纤维化区域越宽越厚,生存率越低。尽管这一发现的预后重要性在统计学上不显著,但我们认为,特别是纤维化区域的水平宽度可能是既往有消退的薄黑色素瘤的一个有价值的预后指标。

相似文献

1
Partial regression in thin primary cutaneous malignant melanomas clinical stage I. A study of 486 cases.I期临床的原发性皮肤薄恶性黑色素瘤的部分回归。486例研究。
Virchows Arch A Pathol Anat Histopathol. 1985;408(2-3):241-7. doi: 10.1007/BF00707986.
2
Regression in thin malignant melanoma. Microscopic diagnosis and prognostic importance.薄恶性黑色素瘤的消退。显微镜诊断及预后意义。
Arch Dermatol. 1985 Sep;121(9):1127-31.
3
Thin malignant melanomas with regression and metastases.伴有消退和转移的薄型恶性黑色素瘤。
Arch Dermatol. 1987 Oct;123(10):1326-30.
4
Regression in malignant melanoma. A histologic feature without independent prognostic significance.恶性黑色素瘤中的消退。一种无独立预后意义的组织学特征。
Cancer. 1985 Nov 1;56(9):2287-91. doi: 10.1002/1097-0142(19851101)56:9<2287::aid-cncr2820560924>3.0.co;2-y.
5
The regressing thin malignant melanoma: a distinctive lesion with metastatic potential.消退性薄恶性黑色素瘤:一种具有转移潜能的独特病变。
Cancer. 1978 Nov;42(5):2282-92. doi: 10.1002/1097-0142(197811)42:5<2282::aid-cncr2820420528>3.0.co;2-v.
6
Thin regressing malignant melanoma: significance of concurrent regional lymph node metastases.薄型消退性恶性黑色素瘤:同时存在区域淋巴结转移的意义
Histopathology. 1989 Sep;15(3):257-65. doi: 10.1111/j.1365-2559.1989.tb03076.x.
7
Regression in malignant melanoma.恶性黑色素瘤的消退
J Am Acad Dermatol. 1983 Mar;8(3):363-8. doi: 10.1016/s0190-9622(83)70040-x.
8
Prognosis in patients with thin malignant melanoma: influence of regression.薄型恶性黑色素瘤患者的预后:消退的影响
Histopathology. 1983 Sep;7(5):673-80. doi: 10.1111/j.1365-2559.1983.tb02279.x.
9
The prognostic significance of ulceration of cutaneous melanoma.皮肤黑色素瘤溃疡的预后意义。
Cancer. 1980 Jun 15;45(12):3012-7. doi: 10.1002/1097-0142(19800615)45:12<3012::aid-cncr2820451223>3.0.co;2-o.
10
Prognostic factors in thin cutaneous malignant melanoma.薄型皮肤恶性黑色素瘤的预后因素
Cancer. 1994 May 1;73(9):2324-32. doi: 10.1002/1097-0142(19940501)73:9<2324::aid-cncr2820730914>3.0.co;2-5.

引用本文的文献

1
Significance of Primary Melanoma Regression on Local Infiltrate and Outcome.原发性黑色素瘤消退对局部浸润及预后的意义。
Dermatol Pract Concept. 2022 Jan 1;12(1):e2022034. doi: 10.5826/dpc.1201a34. eCollection 2022 Feb.
2
Regression in primary cutaneous melanoma: etiopathogenesis and clinical significance.原发性皮肤黑色素瘤的消退:病因发病机制及临床意义。
Lab Invest. 2017 Jun;97(6):657-668. doi: 10.1038/labinvest.2017.8. Epub 2017 Feb 27.
3
Outcome of sentinel lymph node biopsy and prognostic implications of regression in thin malignant melanoma.

本文引用的文献

1
Biologic behavior of thin malignant melanomas with regressive changes.伴有退行性改变的薄型恶性黑色素瘤的生物学行为
Arch Surg. 1983 Aug;118(8):992. doi: 10.1001/archsurg.1983.01390080094025.
2
Biologic behavior of thin malignant melanomas with regressive changes.
Arch Surg. 1983 Jan;118(1):41-4. doi: 10.1001/archsurg.1983.01390010031008.
3
Metastases of thin melanomas.薄型黑色素瘤的转移
Cancer. 1983 Feb 1;51(3):553-6. doi: 10.1002/1097-0142(19830201)51:3<553::aid-cncr2820510332>3.0.co;2-t.
前哨淋巴结活检的结果及薄型恶性黑色素瘤消退的预后意义。
Melanoma Res. 2012 Aug;22(4):302-9. doi: 10.1097/CMR.0b013e328353e673.
4
High lymphatic vessel density and lymphatic invasion underlie the adverse prognostic effect of radial growth phase regression in melanoma.高淋巴管密度和淋巴管浸润是黑色素瘤放射状生长阶段消退不良预后的基础。
Am J Surg Pathol. 2011 Feb;35(2):235-42. doi: 10.1097/PAS.0b013e3182036ccd.
5
[Regression in malignant melanoma. Definition, etiopathogenesis, morphology and differential diagnosis].[恶性黑色素瘤的消退。定义、病因发病机制、形态学及鉴别诊断]
Pathologe. 2007 Nov;28(6):453-63. doi: 10.1007/s00292-007-0937-3.
6
Bcl-2 expression in metastatic malignant melanoma. Importance for the therapeutic efficacy of biochemotherapy.Bcl-2在转移性恶性黑色素瘤中的表达。对生物化疗疗效的重要性。
Cancer Immunol Immunother. 2003 Apr;52(4):249-54. doi: 10.1007/s00262-003-0373-z. Epub 2003 Mar 4.
7
Biochemotherapy of metastatic malignant melanoma. Predictive value of tumour-infiltrating lymphocytes.转移性恶性黑色素瘤的生物化疗。肿瘤浸润淋巴细胞的预测价值。
Br J Cancer. 2001 Dec 14;85(12):1871-7. doi: 10.1054/bjoc.2001.2169.
8
Tumour-infiltrating lymphocytes in metastatic malignant melanoma and response to interferon alpha treatment.转移性恶性黑色素瘤中的肿瘤浸润淋巴细胞及对α干扰素治疗的反应
Br J Cancer. 1996 Sep;74(5):670-6. doi: 10.1038/bjc.1996.420.
9
Morphometric, DNA and PCNA in thin malignant melanomas.
Med Oncol Tumor Pharmacother. 1993;10(3):87-94. doi: 10.1007/BF02987774.
10
Regressing thin cutaneous malignant melanomas (< or = 1.0 mm) are associated with angiogenesis.消退性薄皮肤恶性黑色素瘤(≤1.0毫米)与血管生成有关。
Am J Pathol. 1993 Jul;143(1):99-104.
4
Prognosis in patients with thin malignant melanoma: influence of regression.薄型恶性黑色素瘤患者的预后:消退的影响
Histopathology. 1983 Sep;7(5):673-80. doi: 10.1111/j.1365-2559.1983.tb02279.x.
5
Experience of thin cutaneous melanomas (less than 0.76 mm and less than 0.85 mm thick) in a large plastic surgery unit: a 5 to 17 year follow-up.
Br J Plast Surg. 1984 Oct;37(4):501-6. doi: 10.1016/0007-1226(84)90139-5.
6
Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma.厚度、横截面积及浸润深度在皮肤黑色素瘤预后中的作用
Ann Surg. 1970 Nov;172(5):902-8. doi: 10.1097/00000658-197011000-00017.
7
Survival with primary cutaneous malignant melanoma, evaluated from 2012 cases. A multivariate regression analysis.对2012例原发性皮肤恶性黑色素瘤患者的生存情况进行多因素回归分析。
Virchows Arch A Pathol Anat Histopathol. 1985;406(2):179-95. doi: 10.1007/BF00737084.
8
Tumor thickness, level of invasion and node dissection in stage I cutaneous melanoma.I期皮肤黑色素瘤的肿瘤厚度、浸润程度及淋巴结清扫情况
Ann Surg. 1975 Nov;182(5):572-5. doi: 10.1097/00000658-197511000-00007.
9
Spontaneous regression of melanoma.黑色素瘤的自发消退
Pathology. 1975 Apr;7(2):91-9. doi: 10.3109/00313027509092702.
10
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.需要对每位患者进行长期观察的随机临床试验的设计与分析。II. 分析与示例。
Br J Cancer. 1977 Jan;35(1):1-39. doi: 10.1038/bjc.1977.1.